Second-Generation AOH1996 Analogues with Enhanced Pharmacological Properties for Targeting PCNA
Second-generation AOH analogues with enhanced pharmacological properties were created through scaffold optimization, and both compounds induced robust G2/M arrest at lower concentrations than the parent molecule and significantly enhanced transcription–replication conflicts in pancreatic cancer cells.